Advanced Search
Contact | Corporate | Help

Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid

Sponsors:
  • University of Alabama at Birmingham
  • Genentech
  • Biogen Idec
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Ocular Cicatricial Pemphigoid
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Rituximab
Enrollment:
5

Additional information about NCT00584935.


SourceSolution © 2008-2012